| Ident. | Authors (with country if any) | Title |
|---|
| 000947 (2020) |
Lenka Petroušová [République tchèque] ; Simona Da Silva ; Lud K Rožnovsk ; Irena Martinková | [Clinical progression of the first wave of novel coronavirus infection in Ostrava]. |
| 000A44 (2020) |
Shio-Shin Jean [Taïwan] ; Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan] | Treatment options for COVID-19: The reality and challenges. |
| 000A47 (2020) |
Waquar Ahsan [Arabie saoudite] ; Shamama Javed [Arabie saoudite] ; Mohammed Al Bratty [Arabie saoudite] ; Hassan A. Alhazmi [Arabie saoudite] ; Asim Najmi [Arabie saoudite] | Treatment of SARS-CoV-2: How far have we reached? |
| 000A53 (2020) |
Hilary Miller-Handley [États-Unis] ; Keith Luckett [États-Unis] ; Amit Govil [États-Unis] | Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function. |
| 000C06 (2020) |
Hye Jin Jeong [Corée du Sud] ; Sein Min [Corée du Sud] ; Heelim Chae [Corée du Sud] ; Sarah Kim [Corée du Sud] ; Gunwoo Lee [Corée du Sud] ; Sung Keon Namgoong [Corée du Sud] ; Keunhong Jeong [Corée du Sud] | Signal amplification by reversible exchange for COVID-19 antiviral drug candidates. |
| 000C29 (2020) |
Gayathri Vaidyanathan | Scientists criticize use of unproven COVID drugs in India. |
| 000C52 (2020) |
Michele Costanzo [Italie] ; Maria Anna Rachele De Giglio [Italie] ; Giovanni Nicola Roviello [Italie] | SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. |
| 000E35 (2020) |
Saba Shamim [Pakistan] ; Maryam Khan [Pakistan] ; Zelal Jaber Kharaba [Émirats arabes unis] ; Munazza Ijaz [Pakistan] ; Ghulam Murtaza [Pakistan] | Potential strategies for combating COVID-19. |
| 000E46 (2020) |
N. Trivedi [États-Unis] ; A. Verma ; D. Kumar | Possible treatment and strategies for COVID-19: review and assessment. |
| 000E56 (2020) |
Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis] ; Ali Pourmand [États-Unis] | Pharmacotherapy in COVID-19; A narrative review for emergency providers. |
| 000E60 (2020) |
Woon Yi Law [Malaisie] ; Mohd Razip Asaruddin [Malaisie] ; Showkat Ahamd Bhawani [Malaisie] ; Samsur Mohamad [Malaisie] | Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). |
| 000E64 (2020) |
James M. Sanders [États-Unis] ; Marguerite L. Monogue [États-Unis] ; Tomasz Z. Jodlowski [États-Unis] ; James B. Cutrell [États-Unis] | Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. |
| 001035 (2020) |
Mohamed Hagar [Arabie saoudite, Égypte] ; Hoda A. Ahmed [Égypte] ; Ghadah Aljohani [Arabie saoudite] ; Omaima A. Alhaddad [Arabie saoudite] | Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations. |
| 001046 (2020) |
Tiago Da Silva Arouche [Brésil] ; Arthur Ferreira Reis [Brésil] ; Anderson Yuri Martins [Brésil] ; Jose Francisco S Costa [Brésil] ; Raul Nunes Carvalho Junior [Brésil] ; Antonio Maia J C Neto [Brésil] | Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking. |
| 001252 (2020) |
Alexandre Duvignaud [France] ; Edouard Lhomme [France] ; Thierry Pistone [France] ; Racha Onaisi [France] ; Rémi Sitta [France] ; Valérie Journot [France] ; Duc Nguyen [France] ; Nathan Peiffer-Smadja [France, Royaume-Uni] ; Antoine Crémer [France] ; Stéphane Bouchet [France] ; Thomas Darnaud [France] ; Delphine Poitrenaud [France] ; Lionel Piroth [France] ; Christine Binquet [France] ; Jean-François Michel [Luxembourg (pays)] ; Benjamin Lefèvre [France] ; David Lebeaux [France] ; Josselin Lebel [France] ; Julie Dupouy [France] ; Caroline Roussillon [France] ; Anne Gimbert [France] ; Linda Wittkop [France] ; Rodolphe Thiébaut [France] ; Joanna Orne-Gliemann [France] ; Jean-Philippe Joseph [France] ; Laura Richert [France] ; Xavier Anglaret [France] ; Denis Malvy [France] | Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). |
| 001256 (2020) |
Hiroyuki Fujii [Japon] ; Taisuke Tsuji [Japon] ; Tatsuya Yuba [Japon] ; Shunya Tanaka [Japon] ; Yoshifumi Suga [Japon] ; Aosa Matsuyama [Japon] ; Ayaka Omura [Japon] ; Shinsuke Shiotsu [Japon] ; Chieko Takumi [Japon] ; Seiko Ono [Japon] ; Masahito Horiguchi [Japon] ; Noriya Hiraoka [Japon] | High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19. |
| 001279 (2020) |
Immacolata Ambrosino [Italie] ; Elena Barbagelata [Italie] ; Graziamaria Corbi [Italie] ; Tiziana Ciarambino [Oman] ; Cecilia Politi ; Anna Maria Moretti [Italie] | Gender differences in treatment of Coronavirus Disease-2019. |
| 001294 (2020) |
Suzanne J F. Kaptein [Belgique] ; Sofie Jacobs [Belgique] ; Lana Langendries [Belgique] ; Laura Seldeslachts [Belgique] ; Sebastiaan Ter Horst [Belgique] ; Laurens Liesenborghs [Belgique] ; Bart Hens [Belgique] ; Valentijn Vergote [Belgique] ; Elisabeth Heylen [Belgique] ; Karine Barthelemy [France] ; Elke Maas [Belgique] ; Carolien De Keyzer [Belgique] ; Lindsey Bervoets [Belgique] ; Jasper Rymenants [Belgique] ; Tina Van Buyten [Belgique] ; Xin Zhang [Belgique] ; Rana Abdelnabi [Belgique] ; Juanita Pang [Royaume-Uni] ; Rachel Williams [Royaume-Uni] ; Hendrik Jan Thibaut [Belgique] ; Kai Dallmeier [Belgique] ; Robbert Boudewijns [Belgique] ; Jens Wouters [Belgique] ; Patrick Augustijns [Belgique] ; Nick Verougstraete [Belgique] ; Christopher Cawthorne [Belgique] ; Judith Breuer [Royaume-Uni] ; Caroline Solas [France] ; Birgit Weynand [Belgique] ; Pieter Annaert [Belgique] ; Isabel Spriet [Belgique] ; Greetje Vande Velde [Belgique] ; Johan Neyts [Belgique, États-Unis] ; Joana Rocha-Pereira [Belgique] ; Leen Delang [Belgique] | Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. |
| 001356 (2020) |
Wei Liu [République populaire de Chine] ; Pengxiang Zhou [République populaire de Chine] ; Ken Chen [République populaire de Chine] ; Zhikang Ye [République populaire de Chine] ; Fang Liu [République populaire de Chine] ; Xiaotong Li [République populaire de Chine] ; Na He [République populaire de Chine] ; Ziyang Wu [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Xuepeng Gong [République populaire de Chine] ; Qiyu Tang [République populaire de Chine] ; Xin Du [République populaire de Chine] ; Yingqiu Ying [République populaire de Chine] ; Xiaohan Xu [République populaire de Chine] ; Yahui Zhang [République populaire de Chine] ; Jinyu Liu [République populaire de Chine] ; Yun Li [République populaire de Chine] ; Ning Shen [République populaire de Chine] ; Rachel J. Couban [République populaire de Chine] ; Quazi I. Ibrahim [République populaire de Chine] ; Gordon Guyatt [République populaire de Chine] ; Suodi Zhai [Oman] | Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis. |
| 001495 (2020) |
Cristina Carvalho Gouveia ; Luís Campos | Coronavirus Disease 2019: Clinical Review. |
| 001586 (2020) |
Miguel Angel Martinez [Espagne] | Clinical Trials of Repurposed Antivirals for SARS-CoV-2. |
